Description
Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma
€3.03
Brentuximab vedotin: an innovative treatment for patients with Hodgkin and systemic anaplastic large cell lymphoma
You must be logged in to post a review.
Reviews
There are no reviews yet.